Fennec Pharmaceuticals Inc.

United States of America


Create a watch for Fennec Pharmaceuticals Inc.
Total IP 26
Total IP Rank # 57,412
IP Activity Score 2.3/5.0    25
IP Activity Rank # 31,496
Stock Symbol
ISIN CA31447P1009
Market Cap. 171M  (USD)
Industry Biotechnology
Sector Healthcare
Dominant Nice Class Pharmaceutical, veterinary and s...

Patents

Trademarks

13 4
2 0
3 0
4
 
Last Patent 2025 - Anhydrous sodium thiosulfate and...
First Patent 2018 - Method for reducing ototoxicity ...
Last Trademark 2023 - PEDMARQSI
First Trademark 2017 - PEDMARK

Industry (Nice Classification)

Latest Inventions, Goods, Services

2025 Invention Anhydrous sodium thiosulfate and formulations thereof. Described herein is anhydrous sodium thio...
2024 G/S Pharmaceutical preparations, namely, sodium thiosulfate used for the prevention of ototoxicity fr...
Invention Therapeutic uses for sodium thiosulfate formulations. Described herein is anhydrous sodium thiosu...
2022 G/S Patient administration services, namely, enrolling patients in the patient assistance programs of...
Invention Therapeutic uses for sodium thiosulfate and formulations. Described herein is anhydrous sodium th...
Invention Anhydrous sodium thiosulfate and formulations thereof. Described herein is anhydrous sodium thios...
G/S Patient advocacy services, namely, promoting public awareness of pharmaceutical discount opportun...
2019 Invention Formulations of anhydrous sodium thiosulfate. Described herein is anhydrous sodium thiosulfate, ...
Invention Formulations of anhydrous sodium thiosulfate. Described herein is anhydrous sodium thiosulfate, m...
2018 Invention Method for reducing ototoxicity in pediatric patients receiving platinum-based chemotherapy. Desc...